ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 82K)  | Related Articles | Citation Tracking

Treatment of irritant and allergic contact dermatitis
David E. Cohen & Noushin Heidary
 Department of Dermatology, Allergic, Occupational and Environmental Dermatology, New York University School of Medicine, New York
 Address correspondence and reprint requests to: David E. Cohen, MD, MPH, Department of Dermatology, Allergic, Occupational and Environmental Dermatology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, or email: david.cohen@med.nyu.edu.
Copyright Copyright © Blackwell Publishing, Inc., 2004
KEYWORDS
avoidance protocol • contact dermatitis • corticosteroids • immunomodulators • treatment

ABSTRACT:  

AbstractIntroductionConclusionReferences

ABSTRACT:  The treatment of contact dermatitis lies principally in the avoidance of the offending agent. In certain circumstances, avoidance protocols are insurmountable, and therapy is rendered to assuage the inflammatory component and its consequent objective and subjective findings. However, the options thereafter vary, as some patients will require continuous symptomatic therapy despite avoidance of the purported offending agent. This manuscript will review established treatment options for contact dermatitis, such as corticosteroids and dietary manipulation, as well as discuss some promising new therapies from the last decade, such as the immunomodulatory and anti-inflammatory agents.


DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1396-0296.2004.04031.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Latest News & Information
DTH Impact Factor

Sign Up Now
Sign Up Now
Sign Up Now

Sign Up Now

Be the first to know about new research in your field

Sign up for FREE e-alerts from Wiley-Blackwell journals!

Sign Up Now